Rodinia Announces Shareholder Approval of Change of Business
The common shareholders also elected each of the three management nominees as a director of the Company for the ensuing year. The directors are:
- Fred Leigh
- Julian Bharti
- Tito Gandhi
The common shareholders also re-approved the Company's stock option plan (the "Option Plan") in accordance with the requirements of the TSXV Venture Exchange ("TSXV"). The COB, Consolidation, Name Change and the Option Plan are each subject to the final approval by the TSXV.
Other Information
Completion of the COB is subject to a number of conditions, including TSXV acceptance. There can be no assurance that the COB will be completed as proposed or at all.
The TSXV has in no way passed upon the merits of the COB and has neither approved nor disapproved the contents of this press release.
About Rodinia Lithium Inc.:
Rodinia Lithium Inc. is a Canadian mineral exploration and development company.
FORWARD LOOKING STATEMENTS: This news release contains certain forward-looking statements, including statements regarding the COB, the Consolidation, the Name Change and the TSXV granting approval of the COB, Consolidation, Name Change and Option Plan. These statements are subject to a number of risks and uncertainties. Actual results may differ materially from results contemplated by the forward-looking statements. When relying on forward-looking statements to make decisions, investors and others should carefully consider the foregoing factors and other uncertainties and should not place undue reliance on such forward-looking statements. The Company does not undertake to update any forward looking statements, oral or written, made by itself or on its behalf, except as required by applicable law.
NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
Contact
Rodinia Lithium Inc.
Fred Leigh, President and Chief Executive Officer
+1 (416) 861-5933